Michael Marling
Podiatrist · Kansas City, MONPI 1639494586
Payments from drug & device makers
What this record shows
This record is dominated by education: $5,812 of the $9,065 with a category attached, or 64.1%. Acell, Inc. accounts for 64.2% of it on its own, with 31 other manufacturers making up the rest. Reporting peaked in 2019 at $6,019 and has fallen 89.5% since, to $629 in 2025. Among podiatrist clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 179 payments — averaging $50.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acell, Inc.$6K
- Smith+Nephew$541
- Organogenesis Inc.$373
- Paratek Pharmaceuticals, Inc.$337
- Kowa Pharmaceuticals America, Inc.$299
- Acera Surgical, Inc.$252
- plus $1K from 26 others
What the payments were for
- Food & beverage$3,25336%
- Education$5,81264%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acell, Inc. | 3 | $5,823 |
| Smith+Nephew | 39 | $541 |
| Organogenesis Inc. | 14 | $373 |
| Paratek Pharmaceuticals, Inc. | 23 | $337 |
| Kowa Pharmaceuticals America, Inc. | 23 | $299 |
| Acera Surgical, Inc. | 13 | $252 |
| Amgen(2 entities) | 7 | $211 |
| Globus Medical | 5 | $188 |
| Kerecis Limited | 4 | $174 |
| Stryker | 6 | $133 |
| Mimedx Group, Inc. | 5 | $89 |
| Johnson & Johnson | 2 | $66 |
| Integra Lifesciences Corporation | 4 | $65 |
| Abbott | 3 | $58 |
| Polynovo North America LLC | 2 | $47 |
| Bioventus LLC | 3 | $44 |
| Merck | 3 | $38 |
| Baudax Bio Inc. | 2 | $35 |
| Biocomposites Inc | 2 | $34 |
| Treace Medical Concepts, Inc. | 2 | $29 |
| Biotissue Holdings Inc. | 1 | $29 |
| Boston Scientific | 2 | $27 |
| Next Science LLC | 1 | $25 |
| Solventum Corporation | 1 | $22 |
| Nevro Corp. | 1 | $22 |
| Alfasigma USA, Inc. | 1 | $18 |
| Zimmer Biomet | 1 | $16 |
| Aroa Biosurgery Incorporated | 2 | $16 |
| Titan Surgical Group, LLC | 1 | $16 |
| AbbVie | 1 | $15 |
| Medtronic | 1 | $14 |
| Arteriocyte Medical Systems, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,065 in reported general payments places this provider in the 90th percentile of 105 podiatrist providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 12 | $931 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 56 | $698 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 37 | $309 |
| Terbinafine Hcl | 36 | $251 |
| Mupirocin | 19 | $245 |
| Clindamycin Hcl | 19 | $198 |
| Ciprofloxacin Hcl | 11 | $118 |
| Doxycycline Hyclate | 11 | $102 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Kansas City
- Brian WareKansas City$4K
- Erin LewisKansas City$4K
- Thomas BembynistaKansas City$3K
- Chengyu XieKansas City$970
- Luke SchmittKansas City$692
- William DukeJefferson City$54K
- Kiera Benge-SheaSaint Louis$28K
- Thomas BoldryLiberty$19K
- Ryan FrankIndependence$15K
- Neil ErmitanoSaint Louis$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.